Jay Moorin, 10% Owner at AVANIR PHARMACEUTICALS (AVNR), bought 675,053 shares at $0.85 ($552K) on 2008-09-15, disclosed to the SEC on 2008-09-17.
Open-market purchase of $552k AVNR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.85 | 244,449 | $208K | 37.7% |
| 2 | $0.76 | 17,387 | $13K | 2.4% |
| 3 | $0.80 | 413,217 | $331K | 59.9% |
| Total | $0.82 avg | 675,053 | $552K | 100% |
| Filing → |
| IMDZ | SELL | 2015-04-21 | $1.2M | — | Filing → |
| IMDZ | SELL | 2015-03-18 | $1.3M | — | Filing → |
| EGRX | BUY | 2014-02-20 | $5.0M | — | Filing → |